Artificial Neural Networks for the Prediction of Response to Interferon Plus Ribavirin Treatment in Patients with Chronic Hepatitis C

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|17|2101-2109

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.17, 2004-01, pp. : 2101-2109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Peginterferon -2a Plus Ribavirin versus Interferon -2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

By Sullivan S.D.

PharmacoEconomics, Vol. 22, Iss. 4, 2004-01 ,pp. : 257-265

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Peginterferon -2a Plus Ribavirin versus Interferon -2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C

By Arguedas M.

PharmacoEconomics, Vol. 22, Iss. 7, 2004-01 ,pp. : 477-479

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Peginterferon -2a Plus Ribavirin versus Interferon -2b Plus Ribavirin as Initial Therapy for Treatment-Naive Chronic Hepatitis C. The Authors' Reply

By Sullivan S.D.

PharmacoEconomics, Vol. 22, Iss. 7, 2004-01 ,pp. : 478-479

Adis International

Access to resources Recommend Favorite

Financial Impact of Two Different Ways of Evaluating Early Virological Response to Peginterferon- -2b Plus Ribavirin Therapy in Treatment-Naive Patients with Chronic Hepatitis C Virus Genotype 1

By Buti Maria

PharmacoEconomics, Vol. 23, Iss. 10, 2005-01 ,pp. : 1043-1055

Adis International

Access to resources Recommend Favorite

Interferon- + ribavirin more effective in chronic hepatitis C

Inpharma, Vol. 1, Iss. 1315, 2001-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite